Table 5. Cox regression analyses of serum HBsAg (−/+) for LMFS in 642 patients.
| Variable | Univariate (P value) | Multivariate | |
|---|---|---|---|
| HR (95% CI) | P | ||
| Age | 0.831 | ||
| Menstrual status | 0.312 | ||
| Family history | 0.804 | ||
| Histologic grade | 0.238 | ||
| Tumor size | 0.001 | 1.586 (1.098–2.292) | 0.014 |
| Lymph node status | 0.002 | 1.911 (1.315–2.778) | 0.001 |
| ER | 0.094 | ||
| PR | 0.352 | ||
| HER-2 | 0.077 | ||
| Surgery | 0.934 | ||
| HBsAg | 0.046 | 2.450 (1.169–5.135) | 0.018 |
ER, estrogen receptor, PR, progesterone receptor, HER-2, human epidermal growth factor receptor-2; HBsAg, hepatitis B surface antigen, LMFS, liver metastasis-free survival.